DIMENSION
A study to evaluate the effect of SAGE-718 on cognitive function in participants with Huntington's Disease
Phase 2 study testing SAGE-718 in Huntington's disease.
Recruitment endedPhase IINot specifiedISRCTNTreatment trial
Recruiting in: United States
Sponsor: Sage Therapeutics, Inc.
Preparing a short plain-English summary.